Since overexpression of cyclin E promotes cancer development, our work suggests that MAGE-C2 may play an oncogenic activity by decreasing cyclin E ubiquitylation and maintaining cyclin E at a level that favor cell cycle progression in cancer cells. This evidence concerns the gene CCNE1 and cancer.